How strong is a patent?
For a published application or granted patent. You'll need the publication or patent number to start.
What you get
Start with a publication or patent number
Enter a granted patent or published application number. Patenter pulls the claims and text, so there is nothing to upload.
Novelty and non-obviousness analysis against 5M+ prior art
Every claim is rated against the prior art, from likely novel to anticipated, with the references and reasoning behind each rating.
Freedom-to-operate analysis with claim charts
Patents that could block the invention are identified, and their claims are charted element by element to show what is and is not disclosed.
Identify risks and strengths for each asset
Where the patent is vulnerable and where it holds up, with a recommended path such as maintain to grant, narrow claims at prosecution or commission a design-around.
Conservative and aggressive risk posture, per asset
See how the conclusions shift between a cautious and an assertive reading of the evidence, so you weigh the range rather than a single answer.
Assess the risks and commercial potential of the patents you hold.
Know which applications and granted patents in your portfolio are worth licensing, worth spinning out or worth letting go, before you spend on prosecution, maintenance or a licensing conversation.
- →Identify where each patent is vulnerable to challenge
- →Assess commercial potential for each asset
- →Novelty and non-obviousness analysis against 5M+ prior art
- →Freedom-to-operate analysis with claim charts
- →Conservative and aggressive risk posture, per asset
Diligence on a deal timeline.
Run an assessment on every patent and application in a target's portfolio, at a fixed price per asset, and see where the IP is strong, where it's exposed and what to ask the founders.
- →One assessment per patent or application, for the whole portfolio
- →Freedom-to-operate claim charts that flag commercialization risks
- →Conservative and aggressive risk posture, per asset
- →Reports you can attach to an investment memo
Walk into investor meetings with an independent view of your IP.
Assess your own patents and applications for novelty, non-obviousness and freedom to operate, so investors see more than your word for it.
- →Assess each of your published patents and applications
- →Freedom-to-operate analysis with claim charts
- →A recommended path for each asset
- →A report to bring to investor conversations
Novelty review and freedom to operate for every matter.
Run assessments for clients, or for your own company's portfolio, with claim charts your team reviews instead of building from scratch.
- →Novelty and non-obviousness analysis against 5M+ prior art
- →Freedom-to-operate claim charts, element by element
- →Conservative and aggressive risk posture, per asset
- →IP services firms: run assessments for clients at volume
Bulk licensing
Running patent assessments for a team, an office or a firm? Volume licensing is available on request.